Development and Validation of RP-HPLC Method For Simultaneous Determination of Guaifenesin Impurities in Multi Drug Combinations

α
Tigran K. Davtyan
Tigran K. Davtyan
σ
Levon A. Melikyan
Levon A. Melikyan
ρ
Rosa S. Grigoryan
Rosa S. Grigoryan
α Analytical Laboratory Branch, Scientific Center of Drug and Medical Technology Expertise JSC, Ministry of Health of Armenia,

Send Message

To: Author

Development and Validation of RP-HPLC Method For Simultaneous Determination of Guaifenesin Impurities in Multi  Drug Combinations

Article Fingerprint

ReserarchID

PDDTMK3JKI

Development and Validation of RP-HPLC Method For Simultaneous Determination of Guaifenesin Impurities in Multi  Drug Combinations Banner

AI TAKEAWAY

Connecting with the Eternal Ground
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu

Abstract

A High Performance Liquid Chromatographic method was developed and validated for quantitative determination of Guaifenesin impurities including 2-(2-methoxyphenoxy)propane-1,3-diol (β-isomer) and 2methoxyphenol (guaiacol) in different multi drug components pharmaceutical dosage forms, containing guaifenesin, ambroxol hydrochloride and salbutamol sulfate . The different analytical performance parameters such as linearity, precision, accuracy, limit of detection (LOD), limit of Quantification (LOQ) were determined according to International Conference on Harmonization (ICH) Q2B guidelines. The chromatographic separation was achieved on EC NUCLEODUR-100-3C18 (250×4,6 mm, 5μm packing) column using gradient elution of Solvent A (0.1 M ammonium acetate buffer of pH 6.8) and solvent B (acetonitrile : methanol (80:20)) The Ultra Violet spectrophotometric determination was performed at 275 nm. The Linearity of the calibration curves for the analytes in the desired concentration range is good (r2 = 0.999) by High Performance Liquid Chromatography. The LOQ were 1 and 0.1 μg/ml respectively for guaifenesin β-isomer and guaiacol. The average percentage recovery of guaifenesin impurities was found to be within 98.6 -101.2% of range. The developed method can be successfully used for identification and quantification of guaifenesin impurities β-isomer and guaiacol in the presence of guaifenesin, ambroxol hydrochloride and salbutamol sulfate in multi drug components pharmaceutical formulations.

References

12 Cites in Article
  1. I Cerveri,V Brusasco (2010). Revisited role for mucus hypersecretion in the pathogenesis of COPD.
  2. E Houtmeyers,R Gosselink,G Gayan-Ramirez,M Decramer (1999). Effects of drugs on mucus clearance.
  3. R Balsamo,L Lanata,C Egan (2010). Mucoactive drugs.
  4. Jeanclare Seagrave,Helmut Albrecht,David Hill,Duncan Rogers,Gail Solomon (2012). Effects of guaifenesin, N-acetylcysteine, and ambroxol on MUC5AC and mucociliary transport in primary differentiated human tracheal-bronchial cells.
  5. Prabhu Shankar,S Chandrashekharan,S Bolmall,C Baliga,V (2010). Efficacy, safety and tolerability of salbutamol + guaiphenesin + bromhexine (Ascoril) expectorant versus expectorants containing salbutamol and either guaiphenesin or bromhexine in productive cough: a randomised controlled comparative study.
  6. M Yakoot,A Salem,A Omar (2010). Clinical efficacy of farcosolvin syrup (ambroxol–theophylline–guaiphenesin mixture) in the treatment of acute exacerbation of chronic bronchitis.
  7. N Abdelwahab (2012). Determination of ambroxol hydrochloride, guaifenesin, and theophylline in ternary mixtures and in the presence of excipients in different pharmaceutical dosage forms.
  8. J Jain,M Prakash,R Mishra,A Khandhar (2008). Chemometric-assisted RP-HPLC method for the simultaneous determination of ambroxol hydrochloride, terbutaline sulfate, and guaiphenesin in combined dosage form.
  9. A Porel,A Kundu,Sanjukta Haty (2011). Stability-indicating HPLC method for simultaneous determination of terbutaline sulphate, bromhexine hydrochloride and guaifenesin.
  10. Sunil Reddy,K Sudhakar Babu,Navneet Kumar,Y Sasi Sekhar (2011). Development and validation of stability indicating the RP-HPLC method for the estimation of related compounds of guaifenesin in pharmaceutical dosage forms.
  11. Andrew Asirvatham,A Manikandan,K Mailvelan,R Konam,K Rajavel,P (2012). Estimation of guaifenesin in human plasma by liquid chromatography coupled with tandem mass spectroscopy.
  12. I Bhattacharyya,S Bhattacharyya,C Kyal,P Choudhury,B Dhakal,S Ghos (2013). Estimation and validation of stability indicating UV spectrophotometric methos for the determination of guaifenesin in presence of its degradant products.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Tigran K. Davtyan. 2014. \u201cDevelopment and Validation of RP-HPLC Method For Simultaneous Determination of Guaifenesin Impurities in Multi Drug Combinations\u201d. Global Journal of Medical Research - B: Pharma, Drug Discovery, Toxicology & Medicine GJMR-B Volume 14 (GJMR Volume 14 Issue B2): .

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Version of record

v1.2

Issue date

June 3, 2014

Language
en
Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 4424
Total Downloads: 2248
2026 Trends
Related Research

Published Article

A High Performance Liquid Chromatographic method was developed and validated for quantitative determination of Guaifenesin impurities including 2-(2-methoxyphenoxy)propane-1,3-diol (β-isomer) and 2methoxyphenol (guaiacol) in different multi drug components pharmaceutical dosage forms, containing guaifenesin, ambroxol hydrochloride and salbutamol sulfate . The different analytical performance parameters such as linearity, precision, accuracy, limit of detection (LOD), limit of Quantification (LOQ) were determined according to International Conference on Harmonization (ICH) Q2B guidelines. The chromatographic separation was achieved on EC NUCLEODUR-100-3C18 (250×4,6 mm, 5μm packing) column using gradient elution of Solvent A (0.1 M ammonium acetate buffer of pH 6.8) and solvent B (acetonitrile : methanol (80:20)) The Ultra Violet spectrophotometric determination was performed at 275 nm. The Linearity of the calibration curves for the analytes in the desired concentration range is good (r2 = 0.999) by High Performance Liquid Chromatography. The LOQ were 1 and 0.1 μg/ml respectively for guaifenesin β-isomer and guaiacol. The average percentage recovery of guaifenesin impurities was found to be within 98.6 -101.2% of range. The developed method can be successfully used for identification and quantification of guaifenesin impurities β-isomer and guaiacol in the presence of guaifenesin, ambroxol hydrochloride and salbutamol sulfate in multi drug components pharmaceutical formulations.

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Development and Validation of RP-HPLC Method For Simultaneous Determination of Guaifenesin Impurities in Multi Drug Combinations

Levon A. Melikyan
Levon A. Melikyan
Rosa S. Grigoryan
Rosa S. Grigoryan
Tigran K. Davtyan
Tigran K. Davtyan Analytical Laboratory Branch, Scientific Center of Drug and Medical Technology Expertise JSC, Ministry of Health of Armenia,

Research Journals